The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

17 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Design, discovery, modelling, synthesis, and biological evaluation of novel and small, low toxicity s-triazine derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitors.EBI
University of Tartu
Antiretroviral (HIV-1) activity of azulene derivatives.EBI
University of Tartu
Fluorescent photoaffinity probes for mitotic protein kinase Aurora A.EBI
University of Tartu
1-substituted apomorphines as potent dopamine agonists.EBI
University of Tartu
Chemoenzymatic synthesis and evaluation of 3-azabicyclo[3.2.0]heptane derivatives as dopaminergic ligands.EBI
University of Tartu
Conjugates of 5-isoquinolinesulfonylamides and oligo-D-arginine possess high affinity and selectivity towards Rho kinase (ROCK).EBI
University of Tartu
New 2-thioether-substituted apomorphines as potent and selective dopamine D2 receptor agonists.EBI
University of Tartu
Effect of the structure of adenosine mimic of bisubstrate-analog inhibitors on their activity towards basophilic protein kinases.EBI
University of Tartu
N-Substituted-2-alkyl- and 2-arylnorapomorphines: novel, highly active D2 agonists.EBI
University of Tartu
Carbocyclic 3'-deoxyadenosine-based highly potent bisubstrate-analog inhibitor of basophilic protein kinases.EBI
University of Tartu
Construction of Covalent Bisubstrate Inhibitor of Protein Kinase Reacting with Cysteine Residue at Substrate-Binding Site.EBI
University of Tartu
Indole-like Trk receptor antagonists.EBI
University of Tartu
Thiazole- and selenazole-comprising high-affinity inhibitors possess bright microsecond-scale photoluminescence in complex with protein kinase CK2.EBI
University of Tartu
Oligo-aspartic acid conjugates with benzo[c][2,6]naphthyridine-8-carboxylic acid scaffold as picomolar inhibitors of CK2.EBI
University of Tartu
Aryl-benzocycloalkyl amide derivativesBDB
Hoffmann-La Roche
Structural determinants of CDK4 inhibition and design of selective ATP competitive inhibitors.BDB
Cyclacel
Inactivation of purified human recombinant monoamine oxidases A and B by rasagiline and its analogues.BDB
Emory University